New investor is a consortium of leading chinese healthcare companies and financial sponsors.

7 December 2017. Esaote S.p.A. (“Esaote” or the “Company”) announces that a consortium of leading Chinese investors (the “Consortium”) entered into definitive agreements to acquire the entire share capital of the Company.

The transaction gives renewed impetus to Esaote’s plans for further growth and provides the Company with enhanced access to the large and rapidly expanding Chinese medical equipment market. In return, the Consortium will benefit from Esaote’s strong R&D capabilities, its globally recognised brand and industry leading product lines, and extensive international distribution network in the medical imaging sector.